Corrigendum to "The effect of esomeprazole on the upper GI tract release and systemic absorption of mesalazine from colon targeted formulations" [Int. J. Pharm. 619 (2022) 121701].

Van Camp, Arno; Vanuytsel, Tim; Brouwers, Joachim; Augustijns, Patrick

Van Camp, Arno; Vanuytsel, Tim; Brouwers, Joachim; Augustijns, Patrick.

Afiliación

Van Camp A; Drug Delivery and Disposition, KU Leuven, Gasthuisberg O&N II, Herestraat 49 - box 921, 3000 Leuven, Belgium.
Vanuytsel T; Translational Research Center for Gastrointestinal Disorders, TARGID, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.
Brouwers J; Drug Delivery and Disposition, KU Leuven, Gasthuisberg O&N II, Herestraat 49 - box 921, 3000 Leuven, Belgium.
Augustijns P; Drug Delivery and Disposition, KU Leuven, Gasthuisberg O&N II, Herestraat 49 - box 921, 3000 Leuven, Belgium. Electronic address: patrick.augustijns@kuleuven.be.

Int J Pharm ; 655: 124087, 2024 Apr 25.

Article en En | MEDLINE | ID: mdl-38584003

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Int J Pharm Año: 2024 Tipo del documento: Article País de afiliación: Bélgica

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google